Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Atp13a4 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of ATP13A4 mRNA | CTD | PMID:22206623 | Atp13a4 | Rat | 17beta-estradiol | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of ATP13A4 mRNA | CTD | PMID:31614463 | Atp13a4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP13A4 mRNA | CTD | PMID:19770486 | Atp13a4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP13A4 mRNA | CTD | PMID:33387578 | Atp13a4 | Rat | 2-hydroxypropanoic acid | multiple interactions | ISO | Atp13a4 (Mus musculus) | 6480464 | [Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of more ... | CTD | PMID:39922521 | Atp13a4 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of ATP13A4 mRNA | CTD | PMID:30616060 | Atp13a4 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of ATP13A4 mRNA | CTD | PMID:24780913 | Atp13a4 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of ATP13A4 mRNA | CTD | PMID:28959563 | Atp13a4 | Rat | aflatoxin B1 | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of ATP13A4 mRNA | CTD | PMID:19770486 | Atp13a4 | Rat | aflatoxin B1 | decreases methylation | ISO | ATP13A4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ATP13A4 gene | CTD | PMID:27153756 | Atp13a4 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ATP13A4 mRNA | CTD | PMID:35163327 | Atp13a4 | Rat | antirheumatic drug | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of ATP13A4 mRNA | CTD | PMID:24449571 | Atp13a4 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of ATP13A4 gene | CTD | PMID:28931070 | Atp13a4 | Rat | benzo[a]pyrene | increases methylation | ISO | ATP13A4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ATP13A4 exon; Benzo(a)pyrene results in increased methylation of ATP13A4 more ... | CTD | PMID:27901495 | Atp13a4 | Rat | benzo[a]pyrene | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ATP13A4 mRNA | CTD | PMID:32234424 | Atp13a4 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ATP13A4 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | Atp13a4 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ATP13A4 gene | CTD | PMID:28505145 | Atp13a4 | Rat | cantharidin | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Cantharidin results in increased expression of ATP13A4 mRNA | CTD | PMID:36907384 | Atp13a4 | Rat | carbamazepine | affects expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ATP13A4 mRNA | CTD | PMID:25979313 | Atp13a4 | Rat | carbon nanotube | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of ATP13A4 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Atp13a4 | Rat | CGP 52608 | multiple interactions | ISO | ATP13A4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ATP13A4 gene] | CTD | PMID:28238834 | Atp13a4 | Rat | chlordecone | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Chlordecone results in increased expression of ATP13A4 mRNA | CTD | PMID:33711761 | Atp13a4 | Rat | cobalt atom | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Cobalt results in increased expression of ATP13A4 mRNA | CTD | PMID:34468815 | Atp13a4 | Rat | cyclosporin A | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of ATP13A4 mRNA | CTD | PMID:19770486 | Atp13a4 | Rat | dioxygen | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Oxygen deficiency results in decreased expression of ATP13A4 mRNA | CTD | PMID:24205000 | Atp13a4 | Rat | dorsomorphin | multiple interactions | ISO | ATP13A4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Atp13a4 | Rat | ethanol | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Ethanol results in increased expression of ATP13A4 mRNA | CTD | PMID:30319688 | Atp13a4 | Rat | etoposide | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Etoposide results in decreased expression of ATP13A4 mRNA | CTD | PMID:25270620 | Atp13a4 | Rat | folic acid | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ATP13A4 mRNA | CTD | PMID:25629700 | Atp13a4 | Rat | formaldehyde | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ATP13A4 mRNA | CTD | PMID:27905399 | Atp13a4 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ATP13A4 mRNA | CTD | PMID:33387578 | Atp13a4 | Rat | glyphosate | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Glyphosate results in decreased expression of ATP13A4 mRNA | CTD | PMID:33713393 | Atp13a4 | Rat | hydralazine | multiple interactions | ISO | ATP13A4 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP13A4 mRNA | CTD | PMID:17183730 | Atp13a4 | Rat | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of ATP13A4 mRNA | CTD | PMID:20080153 | Atp13a4 | Rat | Licochalcone B | increases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of ATP13A4 mRNA | CTD | PMID:33647349 | Atp13a4 | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of ATP13A4 mRNA | CTD | PMID:22401849 | Atp13a4 | Rat | N-nitrosodiethylamine | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Diethylnitrosamine results in decreased expression of ATP13A4 mRNA | CTD | PMID:17942915 | Atp13a4 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Atp13a4 (Mus musculus) | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ATP13A4 mRNA] | CTD | PMID:17942915 | Atp13a4 | Rat | N-Nitrosopyrrolidine | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of ATP13A4 mRNA | CTD | PMID:32234424 | Atp13a4 | Rat | O-methyleugenol | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of ATP13A4 mRNA | CTD | PMID:32234424 | Atp13a4 | Rat | panobinostat | multiple interactions | ISO | ATP13A4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Atp13a4 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ATP13A4 mRNA | CTD | PMID:33387578 | Atp13a4 | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of ATP13A4 mRNA | CTD | PMID:32680482 | Atp13a4 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ATP13A4 mRNA | CTD | PMID:35163327 | Atp13a4 | Rat | pirinixic acid | multiple interactions | ISO | Atp13a4 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Atp13a4 | Rat | rac-lactic acid | multiple interactions | ISO | Atp13a4 (Mus musculus) | 6480464 | [Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of more ... | CTD | PMID:39922521 | Atp13a4 | Rat | rotenone | increases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | Rotenone results in increased expression of ATP13A4 mRNA | CTD | PMID:29955902 | Atp13a4 | Rat | SB 431542 | multiple interactions | ISO | ATP13A4 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... | CTD | PMID:27188386 | Atp13a4 | Rat | silver atom | affects expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Silver affects the expression of ATP13A4 mRNA | CTD | PMID:27131904 | Atp13a4 | Rat | silver(0) | affects expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Silver affects the expression of ATP13A4 mRNA | CTD | PMID:27131904 | Atp13a4 | Rat | sodium fluoride | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of ATP13A4 protein | CTD | PMID:28918527 | Atp13a4 | Rat | sodium lactate | multiple interactions | ISO | Atp13a4 (Mus musculus) | 6480464 | [Sodium Lactate results in increased abundance of Lactic Acid] which results in increased expression of more ... | CTD | PMID:39922521 | Atp13a4 | Rat | testosterone | decreases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of ATP13A4 mRNA | CTD | PMID:33359661 | Atp13a4 | Rat | tetrachloromethane | increases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ATP13A4 mRNA | CTD | PMID:31919559 | Atp13a4 | Rat | titanium dioxide | decreases expression | ISO | Atp13a4 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ATP13A4 mRNA | CTD | PMID:35295148 | Atp13a4 | Rat | trichostatin A | increases expression | ISO | ATP13A4 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ATP13A4 mRNA | CTD | PMID:24935251 | Atp13a4 | Rat | valproic acid | multiple interactions | ISO | ATP13A4 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ATP13A4 mRNA | CTD | PMID:17183730 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















